Michelle L. Rogers
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Michelle L. Rogers has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Martyn Gordon Boutelle
Department of Bioengineering, Imperial College London, UK
11 shared publications - Chi Leng Leong
Department of Bioengineering, Imperial College, London, UK
8 shared publications - Sally A. N. Gowers
Department of Bioengineering, Imperial College London, UK.
7 shared publications - Isabelle C. Samper
Department of Bioengineering, Imperial College, London, UK
5 shared publications Clemens Pahl
Department of Basic and Clinical Neuroscience, Kings College London, UK
3 shared publicationsMartyn G. Boutelle
Department of Bioengineering, Imperial College London, London SW7 2AZ, United Kingdom;
3 shared publications
Latest Publications
- 24 January 2020
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 145 (5) , 1894-1902
Real-time neurochemical measurement of dynamic metabolic events during cardiac arrest and resuscitation in a porcine model
This work describes a fully-integrated portable microfluidic analysis system for real-time monitoring of dynamic changes in glucose and lactate occurring in the brain as a result of cardiac arrest and resuscitation.
- 24 January 2020
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 145 (5) , 1894-1902
Real-time neurochemical measurement of dynamic metabolic events during cardiac arrest and resuscitation in a porcine model
This work describes a fully-integrated portable microfluidic analysis system for real-time monitoring of dynamic changes in glucose and lactate occurring in the brain as a result of cardiac arrest and resuscitation.
- Open Access
- 10 July 2019
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 19 (15) , 2537-2548
Clinical translation of microfluidic sensor devices: focus on calibration and analytical robustness
Modular platform providing the building blocks to translate specialised microfluidics from the laboratory to a clinical environment.
- 10 July 2019
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 19 (15) , 2537-2548
Open AccessClinical translation of microfluidic sensor devices: focus on calibration and analytical robustness
Modular platform providing the building blocks to translate specialised microfluidics from the laboratory to a clinical environment.
- Open Access
- 16 May 2019
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 19 (11) , 2038-2048
3D printed microfluidic device for online detection of neurochemical changes with high temporal resolution in human brain microdialysate
Microfluidic devices optimised for real-time monitoring of the human brain.
- 16 May 2019
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 19 (11) , 2038-2048
Open Access3D printed microfluidic device for online detection of neurochemical changes with high temporal resolution in human brain microdialysate
Microfluidic devices optimised for real-time monitoring of the human brain.
- Open Access
- 1 August 2018
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 73, 109
Towards a minimally invasive device for continuous monitoring of beta-lactam antibiotics
- 1 August 2018
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 73, 109
Open AccessTowards a minimally invasive device for continuous monitoring of beta-lactam antibiotics
- Open Access
- 9 March 2018
- Published by Wiley in Chemphyschem
- Vol. 19 (10) , 1215-1225
A High‐Performance Application Specific Integrated Circuit for Electrical and Neurochemical Traumatic Brain Injury Monitoring
This paper presents the first application specific integrated chip (ASIC) for the monitoring of patients who have suffered a Traumatic Brain Injury (TBI). By monitoring the neurophysiological (ECoG) and neurochemical (glucose, lactate and potassium) signals of the injured human brain tissue, it is possible to detect spreading depolarisations, which have been shown to be associated with poor TBI patient outcome. This paper describes the testing of a new 7.5 mm2 ASIC fabricated in the commercially available AMS 0.35 μm CMOS technology. The ASIC has been designed to meet the demands of processing the injured brain tissue's ECoG signals, recorded by means of depth or brain surface electrodes, and neurochemical signals, recorded using microdialysis coupled to microfluidics‐based electrochemical biosensors. The potentiostats use switchedcapacitor charge integration to record currents with 100 fA resolution, and allow automatic gain changing to track the falling sensitivity of a biosensor. This work supports the idea of a “behind the ear” wireless microplatform modality, which could enable the monitoring of currently non‐monitored mobile TBI patients for the onset of secondary brain injury.
- 9 March 2018
- Published by Wiley in Chemphyschem
- Vol. 19 (10) , 1215-1225
Open AccessA High‐Performance Application Specific Integrated Circuit for Electrical and Neurochemical Traumatic Brain Injury Monitoring
This paper presents the first application specific integrated chip (ASIC) for the monitoring of patients who have suffered a Traumatic Brain Injury (TBI). By monitoring the neurophysiological (ECoG) and neurochemical (glucose, lactate and potassium) signals of the injured human brain tissue, it is possible to detect spreading depolarisations, which have been shown to be associated with poor TBI patient outcome. This paper describes the testing of a new 7.5 mm2 ASIC fabricated in the commercially available AMS 0.35 μm CMOS technology. The ASIC has been designed to meet the demands of processing the injured brain tissue's ECoG signals, recorded by means of depth or brain surface electrodes, and neurochemical signals, recorded using microdialysis coupled to microfluidics‐based electrochemical biosensors. The potentiostats use switchedcapacitor charge integration to record currents with 100 fA resolution, and allow automatic gain changing to track the falling sensitivity of a biosensor. This work supports the idea of a “behind the ear” wireless microplatform modality, which could enable the monitoring of currently non‐monitored mobile TBI patients for the onset of secondary brain injury.
- 30 October 2017
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 90 (1) , 2-18
Chemical Monitoring in Clinical Settings: Recent Developments toward Real-Time Chemical Monitoring of Patients
- 30 October 2017
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 90 (1) , 2-18
Chemical Monitoring in Clinical Settings: Recent Developments toward Real-Time Chemical Monitoring of Patients
- Open Access
- 22 October 2016
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 37 (5) , 1883-1895
Simultaneous monitoring of potassium, glucose and lactate during spreading depolarization in the injured human brain – Proof of principle of a novel real-time neurochemical analysis system, continuous online microdialysis
Spreading depolarizations occur spontaneously and frequently in injured human brain. They propagate slowly through injured tissue often cycling around a local area of damage. Tissue recovery after an spreading depolarization requires greatly augmented energy utilisation to normalise ionic gradients from a virtually complete loss of membrane potential. In the injured brain, this is difficult because local blood flow is often low and unreactive. In this study, we use a new variant of microdialysis, continuous on-line microdialysis, to observe the effects of spreading depolarizations on brain metabolism. The neurochemical changes are dynamic and take place on the timescale of the passage of an spreading depolarization past the microdialysis probe. Dialysate potassium levels provide an ionic correlate of cellular depolarization and show a clear transient increase. Dialysate glucose levels reflect a balance between local tissue glucose supply and utilisation. These show a clear transient decrease of variable magnitude and duration. Dialysate lactate levels indicate non-oxidative metabolism of glucose and show a transient increase. Preliminary data suggest that the transient changes recover more slowly after the passage of a sequence of multiple spreading depolarizations giving rise to a decrease in basal dialysate glucose and an increase in basal dialysate potassium and lactate levels.
- 22 October 2016
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 37 (5) , 1883-1895
Open AccessSimultaneous monitoring of potassium, glucose and lactate during spreading depolarization in the injured human brain – Proof of principle of a novel real-time neurochemical analysis system, continuous online microdialysis
Spreading depolarizations occur spontaneously and frequently in injured human brain. They propagate slowly through injured tissue often cycling around a local area of damage. Tissue recovery after an spreading depolarization requires greatly augmented energy utilisation to normalise ionic gradients from a virtually complete loss of membrane potential. In the injured brain, this is difficult because local blood flow is often low and unreactive. In this study, we use a new variant of microdialysis, continuous on-line microdialysis, to observe the effects of spreading depolarizations on brain metabolism. The neurochemical changes are dynamic and take place on the timescale of the passage of an spreading depolarization past the microdialysis probe. Dialysate potassium levels provide an ionic correlate of cellular depolarization and show a clear transient increase. Dialysate glucose levels reflect a balance between local tissue glucose supply and utilisation. These show a clear transient decrease of variable magnitude and duration. Dialysate lactate levels indicate non-oxidative metabolism of glucose and show a transient increase. Preliminary data suggest that the transient changes recover more slowly after the passage of a sequence of multiple spreading depolarizations giving rise to a decrease in basal dialysate glucose and an increase in basal dialysate potassium and lactate levels.
- Open Access
- 15 October 2016
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 408 (29) , 8427-8435
Evaluation of a minimally invasive glucose biosensor for continuous tissue monitoring
We describe here a minimally invasive glucose biosensor based on a microneedle array electrode fabricated from an epoxy-based negative photoresist (SU8 50) and designed for continuous measurement in the dermal compartment with minimal pain. These minimally invasive, continuous monitoring sensor devices (MICoMS) were produced by casting the structures in SU8 50, crosslinking and then metallising them with platinum or silver to obtain the working and reference electrodes, respectively. The metallised microneedle array electrodes were subsequently functionalised by entrapping glucose oxidase in electropolymerised polyphenol (PP) film. Sensor performance in vitro showed that glucose concentrations down to 0.5 mM could be measured with a response times (T90) of 15 s. The effect of sterilisation by Co60 irradiation was evaluated. In preparation for further clinical studies, these sensors were tested in vivo in a healthy volunteer for a period of 3–6 h. The sensor currents were compared against point measurements obtained with a commercial capillary blood glucometer. The epoxy MICoMS devices showed currents values that could be correlated with these. Microneedle arrays for continuous glucose monitoring in dermal interstitial fluid
- 15 October 2016
- Published by Springer Nature in Analytical and Bioanalytical Chemistry
- Vol. 408 (29) , 8427-8435
Open AccessEvaluation of a minimally invasive glucose biosensor for continuous tissue monitoring
We describe here a minimally invasive glucose biosensor based on a microneedle array electrode fabricated from an epoxy-based negative photoresist (SU8 50) and designed for continuous measurement in the dermal compartment with minimal pain. These minimally invasive, continuous monitoring sensor devices (MICoMS) were produced by casting the structures in SU8 50, crosslinking and then metallising them with platinum or silver to obtain the working and reference electrodes, respectively. The metallised microneedle array electrodes were subsequently functionalised by entrapping glucose oxidase in electropolymerised polyphenol (PP) film. Sensor performance in vitro showed that glucose concentrations down to 0.5 mM could be measured with a response times (T90) of 15 s. The effect of sterilisation by Co60 irradiation was evaluated. In preparation for further clinical studies, these sensors were tested in vivo in a healthy volunteer for a period of 3–6 h. The sensor currents were compared against point measurements obtained with a commercial capillary blood glucometer. The epoxy MICoMS devices showed currents values that could be correlated with these. Microneedle arrays for continuous glucose monitoring in dermal interstitial fluid
- Open Access
- 19 May 2016
- Published by Frontiers Media SA in Frontiers in Human Neuroscience
- Vol. 10, 212
High-Performance Bioinstrumentation for Real-Time Neuroelectrochemical Traumatic Brain Injury Monitoring
Traumatic brain injury (TBI) has been identified as an important cause of death and severe disability in all age groups and particularly in children and young adults. Central to TBI’s devastation is a delayed secondary injury that occurs in 30-40% of TBI patients each year, while they are in the hospital Intensive Care Unit (ICU). Secondary injuries reduce survival rate after TBI and usually occur within 7 days post-injury. State-of-art monitoring of secondary brain injuries benefits from the acquisition of high-quality and time-aligned electrical data i.e. ElectroCorticoGraphy (ECoG) recorded by means of strip electrodes placed on the brain’s surface, and neurochemical data obtained via rapid sampling microdialysis and microfluidics-based biosensors measuring brain tissue levels of glucose, lactate and potassium. This article progresses the field of multi-modal monitoring of the injured human brain by presenting the design and realisation of a new, compact, medical-grade amperometry, potentiometry and ECoG recording bioinstrumentation. Our combined TBI instrument enables the high-precision, real-time neuroelectrochemical monitoring of TBI patients, who have undergone craniotomy neurosurgery and are treated sedated in the ICU. Electrical and neurochemical test measurements are presented, confirming the high-performance of the reported TBI bioinstrumentation.
- 19 May 2016
- Published by Frontiers Media SA in Frontiers in Human Neuroscience
- Vol. 10, 212
Open AccessHigh-Performance Bioinstrumentation for Real-Time Neuroelectrochemical Traumatic Brain Injury Monitoring
Traumatic brain injury (TBI) has been identified as an important cause of death and severe disability in all age groups and particularly in children and young adults. Central to TBI’s devastation is a delayed secondary injury that occurs in 30-40% of TBI patients each year, while they are in the hospital Intensive Care Unit (ICU). Secondary injuries reduce survival rate after TBI and usually occur within 7 days post-injury. State-of-art monitoring of secondary brain injuries benefits from the acquisition of high-quality and time-aligned electrical data i.e. ElectroCorticoGraphy (ECoG) recorded by means of strip electrodes placed on the brain’s surface, and neurochemical data obtained via rapid sampling microdialysis and microfluidics-based biosensors measuring brain tissue levels of glucose, lactate and potassium. This article progresses the field of multi-modal monitoring of the injured human brain by presenting the design and realisation of a new, compact, medical-grade amperometry, potentiometry and ECoG recording bioinstrumentation. Our combined TBI instrument enables the high-precision, real-time neuroelectrochemical monitoring of TBI patients, who have undergone craniotomy neurosurgery and are treated sedated in the ICU. Electrical and neurochemical test measurements are presented, confirming the high-performance of the reported TBI bioinstrumentation.
- 1 January 2016
- Published by Elsevier in Journal of Surgical Research
- Vol. 200 (1) , 332-345
Rapid sampling microdialysis as a novel tool for parenchyma assessment during static cold storage and hypothermic machine perfusion in a translational ex vivo porcine kidney model
- 1 January 2016
- Published by Elsevier in Journal of Surgical Research
- Vol. 200 (1) , 332-345
Rapid sampling microdialysis as a novel tool for parenchyma assessment during static cold storage and hypothermic machine perfusion in a translational ex vivo porcine kidney model